129 related articles for article (PubMed ID: 9327946)
21. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
Abekawa T; Honda M; Ito K; Koyama T
Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
[TBL] [Abstract][Full Text] [Related]
22. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.
Caine SB; Negus SS; Mello NK; Patel S; Bristow L; Kulagowski J; Vallone D; Saiardi A; Borrelli E
J Neurosci; 2002 Apr; 22(7):2977-88. PubMed ID: 11923462
[TBL] [Abstract][Full Text] [Related]
23. Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells.
Dwyer DS; Liu Y; Bradley RJ
Neurosci Lett; 1999 Oct; 274(3):151-4. PubMed ID: 10548412
[TBL] [Abstract][Full Text] [Related]
24. The discovery of potent and selective dopamine D4 receptor antagonists.
Faraci WS; Zorn SH; Sanner MA; Fliri A
Curr Opin Chem Biol; 1998 Aug; 2(4):535-40. PubMed ID: 9736928
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110.
Park WK; Jeong D; Yun CW; Lee S; Cho H; Kim GD; Koh HY; Pae AN; Cho YS; Choi KI; Jung JY; Jung SH; Kong JY
Pharmacol Res; 2003 Dec; 48(6):615-22. PubMed ID: 14527827
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Seeman P; Tallerico T
Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
[TBL] [Abstract][Full Text] [Related]
27. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Protais P; Chagraoui A; Arbaoui J; Mocaër E
Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
[TBL] [Abstract][Full Text] [Related]
28. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR
J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of JNJ-42314415, a centrally active phosphodiesterase 10A (PDE10A) inhibitor: a comparison of PDE10A inhibitors with D2 receptor blockers as potential antipsychotic drugs.
Megens AA; Hendrickx HM; Hens KA; Fonteyn I; Langlois X; Lenaerts I; Somers MV; de Boer P; Vanhoof G
J Pharmacol Exp Ther; 2014 Apr; 349(1):138-54. PubMed ID: 24421319
[TBL] [Abstract][Full Text] [Related]
30. Antagonistic effects of isofloxythepin on dopamine D1 and D2 receptors and behaviors in rats.
Lau YS; Fung YK; Anderson TM
Gen Pharmacol; 1997 Nov; 29(5):729-36. PubMed ID: 9347318
[TBL] [Abstract][Full Text] [Related]
31. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Leysen JE; Janssen PM; Megens AA; Schotte A
J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
[TBL] [Abstract][Full Text] [Related]
32. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
33. Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.
Jentsch JD; Taylor JR; Redmond DE; Elsworth JD; Youngren KD; Roth RH
Psychopharmacology (Berl); 1999 Feb; 142(1):78-84. PubMed ID: 10102786
[TBL] [Abstract][Full Text] [Related]
34. Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.
Vauquelin G; Bostoen S; Vanderheyden P; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):337-72. PubMed ID: 22331262
[TBL] [Abstract][Full Text] [Related]
35. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.
Pugsley TA; Shih YH; Whetzel SZ; Zoski K; Van Leeuwen D; Akunne H; Mackenzie R; Heffner TG; Wustrow D; Wise LD
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):219-26. PubMed ID: 11817497
[TBL] [Abstract][Full Text] [Related]
36. Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze.
Cao BJ; Rodgers RJ
Eur J Pharmacol; 1997 Sep; 335(2-3):117-25. PubMed ID: 9369363
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
[TBL] [Abstract][Full Text] [Related]
38. Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus.
Romo-Parra H; Aceves J; Gutiérrez R
Hippocampus; 2005; 15(2):254-9. PubMed ID: 15476261
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
Wilson J; Lin H; Fu D; Javitch JA; Strange PG
J Neurochem; 2001 Apr; 77(2):493-504. PubMed ID: 11299312
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.
Sanner MA; Chappie TA; Dunaiskis AR; Fliri AF; Desai KA; Zorn SH; Jackson ER; Johnson CG; Morrone JM; Seymour PA; Majchrzak MJ; Faraci WS; Collins JL; Duignan DB; Prete Di CC; Lee JS; Trozzi A
Bioorg Med Chem Lett; 1998 Apr; 8(7):725-30. PubMed ID: 9871530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
